MedPage Today17s
BRCA1 Contribution to Prostate Cancer Called Into Question
Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
Lawyer Monthly28m
Zantac Lawsuit: Illinois Jury Rules in Favor of Boehringer Ingelheim
An Illinois jury sided with Boehringer Ingelheim in a Zantac cancer lawsuit. Learn about the legal angles, previous trial ...